These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29805085)

  • 1. Current status of sublingual immunotherapy for allergic rhinitis in Japan.
    Masuyama K; Matsuoka T; Kamijo A
    Allergol Int; 2018 Jul; 67(3):320-325. PubMed ID: 29805085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen Stability and Immunological Reactivity during Co-dissolution and Incubation of House Dust Mite and Japanese Cedar Pollen SLIT-Tablets.
    Watanabe A; Yamamoto T; Matsuhara H; Matsui H; Nakazawa H; Lund K; Ohashi-Doi K
    Biol Pharm Bull; 2020 Oct; 43(10):1448-1450. PubMed ID: 32759600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
    Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K
    Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y; Yokomoto Y; Ohashi-Doi K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
    Nolte H; Maloney J
    Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
    Gotoh M; Okubo K; Yuta A; Ogawa Y; Nagakura H; Ueyama S; Ueyama T; Kawashima K; Yamamoto M; Fujieda S; Sakashita M; Sakamoto H; Iwasaki N; Mori E; Endo T; Ohta N; Kitazawa H; Okano M; Asako M; Takada M; Terada T; Inaka Y; Yonekura S; Matsuoka T; Kaneko S; Hata H; Hijikata N; Tanaka H; Masuyama K; Okamoto Y
    Allergol Int; 2020 Jan; 69(1):104-110. PubMed ID: 31421989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
    J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens.
    Fujii T; Kitamura Y; Kamimura S; Ishitani K; Takeda N
    Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):36-42. PubMed ID: 35155781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study From Kashmir.
    Baba SM; Rasool R; Gull A; Qureshi TA; Beigh AH; Qadri Q; Shah ZA
    Front Immunol; 2021; 12():723814. PubMed ID: 34721385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children.
    Masuyama K; Okamoto Y; Okamiya K; Azuma R; Fujinami T; Riis B; Ohashi-Doi K; Natsui K; Imai T; Okubo K
    Allergy; 2018 Dec; 73(12):2352-2363. PubMed ID: 30043449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis.
    Okamoto Y; Fujieda S; Okano M; Yoshida Y; Kakudo S; Masuyama K
    Allergy; 2017 Mar; 72(3):435-443. PubMed ID: 27471838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. House dust mite sublingual immunotherapy in allergic rhinitis.
    Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
    Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis.
    Jordakieva G; Kundi M; Lemell P; Zieglmayer R; Zieglmayer P; Godnic-Cvar J; Jensen-Jarolim E
    Sci Rep; 2017 May; 7(1):2555. PubMed ID: 28566688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis.
    Meteran H; Backer V
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1127-1133. PubMed ID: 31584839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.